These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21272466)

  • 21. Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis.
    Montagnese S; Jackson C; Morgan MY
    J Hepatol; 2007 Mar; 46(3):447-58. PubMed ID: 17239476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histamine H1 blocker hydroxyzine improves sleep in patients with cirrhosis and minimal hepatic encephalopathy: a randomized controlled pilot trial.
    Spahr L; Coeytaux A; Giostra E; Hadengue A; Annoni JM
    Am J Gastroenterol; 2007 Apr; 102(4):744-53. PubMed ID: 17222324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy.
    Sharma P; Sharma BC; Puri V; Sarin SK
    J Hepatol; 2007 Jul; 47(1):67-73. PubMed ID: 17459511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatosensory evoked potentials and number connection test in the detection of subclinical hepatic encephalopathy.
    Yen CL; Liaw YF
    Hepatogastroenterology; 1990 Jun; 37(3):332-4. PubMed ID: 2373465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
    Cadranel JF; el Younsi M; Pidoux B; Zylberberg P; Benhamou Y; Valla D; Opolon P
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):325-9. PubMed ID: 7600138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy.
    Hassanein T; Blei AT; Perry W; Hilsabeck R; Stange J; Larsen FS; Brown RS; Caldwell S; McGuire B; Nevens F; Fontana R
    Am J Gastroenterol; 2009 Jun; 104(6):1392-400. PubMed ID: 19455117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis.
    Compañy L; Zapater P; Pérez-Mateo M; Jover R
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):519-25. PubMed ID: 20010298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal hepatic encephalopathy does not impair health-related quality of life in patients with cirrhosis: a prospective study.
    Wunsch E; Szymanik B; Post M; Marlicz W; Mydłowska M; Milkiewicz P
    Liver Int; 2011 Aug; 31(7):980-4. PubMed ID: 21733087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Optimization of therapy in patients with hepatic cirrhosis and encephalopathy].
    Ivanov AG; Trusov VV
    Klin Med (Mosk); 2008; 86(6):62-6. PubMed ID: 18720715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.
    Mínguez B; García-Pagán JC; Bosch J; Turnes J; Alonso J; Rovira A; Córdoba J
    Hepatology; 2006 Apr; 43(4):707-14. PubMed ID: 16557541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver function, age, and portasystemic encephalopathy.
    Kardel T
    Neth J Med; 1974; 17(2):50-3. PubMed ID: 4839374
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shunts.
    Ortiz M; Córdoba J; Alonso J; Rovira A; Quiroga S; Jacas C; Esteban R; Guardia J
    J Hepatol; 2004 Mar; 40(3):552-7. PubMed ID: 15123374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased signals seen in globus pallidus in T1-weighted magnetic resonance imaging in cirrhotics are not suggestive of chronic hepatic encephalopathy.
    Thuluvath PJ; Edwin D; Yue NC; deVilliers C; Hochman S; Klein A
    Hepatology; 1995 Feb; 21(2):440-2. PubMed ID: 7843718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subclinical hepatic encephalopathy: how best to diagnose?
    Chalasani N; Gitlin N
    Am J Gastroenterol; 1997 May; 92(5):905-6. PubMed ID: 9149218
    [No Abstract]   [Full Text] [Related]  

  • 37. [Serum concentration of zinc in patients with liver cirrhosis with and without chronic hepatic encephalopathy. Results of a prospective study].
    Garcia-Compean D; Perez-Martinez C; Cuellar JA; Barragan RF; Piñeyro Lopez A
    Gastroenterol Clin Biol; 1994; 18(3):295-6. PubMed ID: 7926452
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of administration of Escherichia coli Nissle (Mutaflor) on intestinal colonisation, endo-toxemia, liver function and minimal hepatic encephalopathy in patients with liver cirrhosis].
    Lata J; Juránková J; Príbramská V; Fric P; Senkyrík M; Díte P; Kroupa R
    Vnitr Lek; 2006 Mar; 52(3):215-9. PubMed ID: 16722152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cirrhotic encephalopathy].
    Degos JD
    Rev Prat; 1976 Nov; 26(51):3641-8. PubMed ID: 996411
    [No Abstract]   [Full Text] [Related]  

  • 40. [Propranolol, hepatic encephalopathy and blood levels of ammonia in hepatic cirrhosis].
    Errico M; Giacobbe A; Facciorusso D; Simone P; Conoscitore P; De Maio ; Spirito F
    Minerva Dietol Gastroenterol; 1987; 33(3):223-6. PubMed ID: 3670672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.